Daws D. Ryan 4

What Happened

• Daws D. Ryan, Chief Financial Officer of enGene Holdings Inc. (ENGN), received a derivative award covering 220,000 shares on January 30, 2026. The Form 4 reports the acquisition price as $0.00, indicating this was a compensation grant (option award), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-01-30; Form 4 filed 2026-02-03 (timely within the 2-business-day rule).
• Transaction type/code: Award/other acquisition (A) — derivative instrument reported.
• Shares/options granted: 220,000 (reported acquisition amount); reported price $0.00.
• Vesting: This option vests monthly in substantially equal amounts over 48 months, subject to continued service (footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Not a sale or purchase of shares on the open market; no immediate cash changed hands.

Context

• This is a standard executive compensation grant (an option award) intended to incent ongoing service; vesting spreads the economic benefit over four years.
• Such grants are routine and do not by themselves indicate insider buying or selling sentiment.